Skip to content

Exploring the Patterns of Traditional Chinese Medicine Usage and Clinical Efficacy in Postmenopausal Ischemic Stroke Based on Literature Review and Real-World Studies

Exploring the Patterns of Traditional Chinese Medicine Usage and Clinical Efficacy in Postmenopausal Ischemic Stroke Based on Literature Review and Real-World Studies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000490
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Observation group:Conventional treatment + Chinese herbal decoction
Control group:Conventional treatment (without Chinese herbal decoction)

Sponsors

Hunan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for Western medicine ischemic stroke and traditional Chinese medicine ischemic stroke; (2) Patients aged over 40 years with menopause; (3) Patients with complete traditional Chinese medicine prescription records during hospitalization.

Exclusion criteria

Exclusion criteria: (1) Patients diagnosed with other cerebral diseases by head CT or MRI, such as cerebral hemorrhage, brain tumor, traumatic brain injury, etc.; (2) Patients with severe heart, liver, or kidney dysfunction or failure, or severe hemorrhagic diseases within the past 3 months; (3) Patients with other severe comorbidities and complications affecting drug evaluation; (4) Legally defined disabled patients affecting neurological function assessment; (5) Patients with severe alcohol/drug abuse history or other conditions that may complicate enrollment or reduce feasibility as per judgment.

Design outcomes

Primary

MeasureTime frame
Efficacy indicators (NIHSS score, TCM syndrome score, BI score, mRS score);

Secondary

MeasureTime frame
Relevant drug treatment information (collecting the traditional Chinese medicine prescriptions used by the patient, such as drug frequency, four natures of the drug, five flavors of the drug, meridian tropism of the drug, drug efficacy, frequency of drug pairs, and other medication situations, etc.);Disease information (vital signs, current medical history, diagnostic information of the disease, information from the four diagnostic methods, infarct location, etiological classification, symptoms, disease stage, TCM syndrome type, course of disease, stroke recurrence, length of hospital stay, comorbid complications after cerebral infarction, number of hospitalizations, past medical history, family history, etc.);Laboratory and imaging indicators (blood routine, blood lipids, blood glucose, liver function, kidney function, coagulation function, inflammatory and immune markers, electrocardiogram, brain CT, etc.);

Countries

China

Contacts

Public ContactQin Lihua

Hunan University of Traditional Chinese Medicine

479157643@qq.com15974203263

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026